Tranquility Partners LLC Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tranquility Partners LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.3% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,787 shares of the healthcare conglomerate’s stock after selling 488 shares during the quarter. UnitedHealth Group accounts for about 1.7% of Tranquility Partners LLC’s holdings, making the stock its 14th largest position. Tranquility Partners LLC’s holdings in UnitedHealth Group were worth $4,458,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the company. Hemington Wealth Management lifted its stake in shares of UnitedHealth Group by 5.9% during the 4th quarter. Hemington Wealth Management now owns 1,126 shares of the healthcare conglomerate’s stock valued at $569,000 after buying an additional 63 shares in the last quarter. Ingalls & Snyder LLC lifted its stake in UnitedHealth Group by 1.7% in the 4th quarter. Ingalls & Snyder LLC now owns 8,670 shares of the healthcare conglomerate’s stock worth $4,386,000 after purchasing an additional 143 shares in the last quarter. McClarren Financial Advisors Inc. lifted its stake in UnitedHealth Group by 62.7% in the 4th quarter. McClarren Financial Advisors Inc. now owns 1,533 shares of the healthcare conglomerate’s stock worth $775,000 after purchasing an additional 591 shares in the last quarter. Hidden Cove Wealth Management LLC purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $214,000. Finally, Naples Global Advisors LLC lifted its stake in UnitedHealth Group by 3.0% in the 4th quarter. Naples Global Advisors LLC now owns 14,468 shares of the healthcare conglomerate’s stock worth $7,319,000 after purchasing an additional 428 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. UBS Group lowered their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Wells Fargo & Company decreased their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Finally, KeyCorp reaffirmed an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Trading Down 1.2 %

NYSE:UNH opened at $527.31 on Thursday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a market cap of $485.27 billion, a price-to-earnings ratio of 34.02, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a 50-day moving average price of $526.25 and a 200-day moving average price of $563.96. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the company posted $5.83 EPS. UnitedHealth Group’s revenue was up 6.8% on a year-over-year basis. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.